PUBLIC COMPANY
save$OPKOPKO HEALTH, INC.
$OPK1.4000+0.72%Miami, FL, USupdated 9h ago
community read0 votes
🐶 often sniffed alongside
top 2pipeline
1
marketed
0
phase 3
0
catalysts ytd
1
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Preclinical
Upcoming
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2Phase 1/2 Study of OPK-88006 in Healthy and Presumed MASH Participants
- phase2Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI
- phase2Pharmacokinetics, Pharmacodynamics, Safety and Tolerability Evaluation of CTAP101 Extended-release Capsules in Pediatric Participants
- phase3Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary Hyperparathyroidism
- phase3Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
- phase2Long Term Follow up Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
- phase2Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19
Insider activity
source: SEC Form 4open-market buys + sells
- Mar 20, 26BUYPAGANELLI JOHN A· director$11K↗
routine RSU / option mechanics (1)
- Mar 18, 26grantUPPALURI SUBBARAO V · director50,000 sh
🐶 Hiring Signal
next earnings Oct 28, 2026
News
no news has mentioned this company yet
Data sources
last refreshed 49m ago
Found something off?
comments(0)
5-min edit window · permanent after that